THEME: "Innovative Approaches to Cancer Prevention, Detection, and Treatment"
Immodx LLC/ Hangzhou Normal University, Singapore
Title: A 2-gene signature within blood leukocytes as diagnostic biomarkers for early colorectal cancer
Dr Wang Yu obtained his B.Sc(Hons) in biological sciences from Nanyang Technological University in 2006 and PhD in biomedical sciences from National University of Singapore in 2011. He completed his post-doctorate training at Genome Institute of Singapore before progressing to a Research PI position at National Cancer Centre Singapore. In his over 15 years of academic research experience focusing on hepatocellular carcinoma, he has published 17 papers in reputable international journals such as Nature Communication and Journal of Hepatology and held five National level grants in Singapore as PI. In 2020, he turned into an entrepreneur to co-found a biotech startup in China, focusing on novel diagnostic solutions based on immune signatures. He has since been awarded the Shaoxing Overseas Innovator Talent Award and China’s National Young Innovator Award (???). He is now an adjunct professor from Hangzhou Normal University and recently appointed to the president of the newly established Zhuji International IVD Innovation Park.